Pharmacists completing the Pediatric Pharmacy Residency Program will be able to provide proficient, confident, and compassionate direct patient care in multiple pediatric patient environments.
Practitioners will be accountable for promoting safe and effective drug usage and achieving optimal drug therapy outcomes as vital members of the health care team. Also, because the University of Maryland School of Pharmacy jointly manages this program with the University of Maryland Hospital for Children (UMHC), the pharmacist will be able to exercise skill in educating other health care professionals, patients, and the community on drug therapy-related topics, and will possess skill in conducting pharmacy practice-related research.
Because this residency program is accredited by the American Society of Health-System Pharmacists, the resident will complete the following ASHP-established outcomes:
- Demonstrate leadership and practice management skills in the pediatric patient care setting.
- Optimize the care of inpatient and outpatient pediatric patients by providing evidence-based, patient-centered medication therapy as an integral part of an interdisciplinary team.
- Serve as an authoritative resource on the optimal use of medications used to treat pediatric patients.
- Evaluate, manage, and improve the medication-use process in pediatric patient care areas.
- Demonstrate excellence in the provision of training or educational activities for pediatric health care professionals, health care professionals in training, and the public.
- Conduct pediatric pharmacy research.
Additionally, our program adheres to the Goals and Objectives for a Post-Graduate Year Two Program in Pediatric Pharmacy set forth by ASHP. These Goals and Objectives can be found in the ASHP Residency Accreditation Regulations and Standards.
PGY-2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY-1 pharmacy residency programs to contribute to the development of clinical pharmacists in pediatric pharmacy practice. PGY-2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete our accredited PGY-2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with pediatric board certification.
Required Learning Experiences:
- General Pediatrics
- Pharmacy Administration/Faculty Experience
- Pediatric Sub-specialties (GI and Heme-Onc)
- Neonatal Intensive Care Unit
- Pediatric Intensive Care Unit
- Pediatric Toxicology
- Ambulatory Care (longitudinal)
- Practice Management Experience (longitudinal)
- Staffing Requirement (two weekend shifts, every third weekend)
- Clinical Consults
Elective Rotation Opportunities:
Each resident will have the opportunity to customize his or her residency experience with the program coordinators.
About the University of Maryland Hospital for Children (UMHC):
In providing the best possible care for children of all ages, the University of Maryland Hospital for Children (UMHC) takes the slogan "Children Are Our Future" very seriously. Recognized statewide and regionally as a center of excellence for children with critical illnesses and complex, chronic conditions, UMHC combines state-of-the-art medicine with family-centered care.
There are a total of 106 inpatient pediatric beds at the University Hospital (32 general inpatient, 14 intermediate care, 10 PICU, 30 NICU, and 10 NICU step-down). There are approximately 4,500 admissions annually, including 1,000 admissions to the PICU/IMC. Our services range from primary care to highly specialized treatment programs that attract patients from the entire mid-Atlantic region.
Number of Available Positions: 1
Qualifications: The resident must be a graduate of an accredited college of pharmacy. The Doctor of Pharmacy degree and Maryland Pharmacy licensure are required. Residents must complete a PGY1 residency prior to starting.
The application deadline is January 1.
Applicants must possess a Doctor of Pharmacy degree and have completed an ASHP-accredited residency in pharmacy practice. The resident will be required to become a licensed pharmacist in the state of Maryland.
Applications for this program will only be accepted through PhORCAS. Reference writers should use the standard reference template in PhORCAS.
- Letter of intent
- Curriculum vitae
- Letters of recommendation (3)
- Official transcripts
International students and permanent residents should contact firstname.lastname@example.org before applying.
Residents who match to this program will be required to come to Baltimore in advance of the July 1st start date for campus orientation; these orientation dates are not known until mid-Spring. These sessions are typically offered on select Mondays in May and June.
Jill A. Morgan, PharmD, BCPS, BCPPS
Director, Pediatric Specialty Pharmacy Residency
Associate Professor of Pharmacy Practice and Science
University of Maryland School of Pharmacy
20 N. Pine Street
Baltimore, MD 21201
Phone: (410) 706-4332
Fax: (410) 706-4012